1. Response to hepatitis B vaccination in high risk population.
- Author
-
Prakash C, Bhatia R, Kumari S, Verghese T, and Datta KK
- Subjects
- Adult, Biomarkers blood, Enzyme-Linked Immunosorbent Assay, Female, Hepatitis B etiology, Hepatitis B Antibodies blood, Hepatitis B Core Antigens immunology, Hepatitis B Surface Antigens blood, Hepatitis B Surface Antigens immunology, Hepatitis B Vaccines administration & dosage, Humans, Immunization Schedule, Male, Middle Aged, Prospective Studies, Time Factors, Vaccines, Synthetic administration & dosage, Hepatitis B prevention & control, Hepatitis B Vaccines immunology, Vaccination methods, Vaccines, Synthetic immunology
- Abstract
Hepatitis B vaccine is well established as very efficacious, but immune response to the vaccine is highly individual specific. A study involving fifty vaccinees was undertaken at the Hepatitis Laboratory, National Institute of Communicable Disease, Delhi. One ml (20 microgram) of Engerix B vaccine (recombinant yeast derived vaccine) was administered in the standard three dose schedule (0, 1 and 6 months). The sero-conversion of the vaccinees was 24%, 66%, 76% and 78% at 1 month, 6 months, 7 months, and 12 months respectively. There was no seroconversion in 22% of the vaccinees. Sero-conversion was assessed using Macro ELISA test (Ausab, Abbott Labs) for Anti HBs reactivity.
- Published
- 2000